Achieving equitable healthcare in global rural and other low-resource communities is challenging due to limited access to healthcare providers. We believe combining on-site medical diagnostic testing with digital health technology is a solution to this problem. Our Sandhill Crane Diagnostics team is uniquely positioned to develop affordable and easy-to-use medical digital health products for use in these settings.
Dr. Sylvia Norman founded Sandhill Crane Diagnostics, Inc. in 2016 to develop technology that will enable delivery of affordable digital health products to rural U.S. populations. She has 20 years of experience in the biotechnology industry, developing diagnostic assays and medical devices for detection of infectious diseases and cancer. Prior to Sandhill Crane Diagnostics, she founded Molecular Diagnostics Consulting to provide efficient and affordable guidance to startup companies developing IVD diagnostic products. Dr. Norman is certified in Project Management and Regulatory Affairs Essentials. She is a contributor to the WHO Prequalification of In Vitro Diagnostics Programme and a peer reviewer for NIH and CARB-X grants.
Dr. Metin Bilgin has a broad and diverse professional background with more than 20 years of work in assay development, genomics and interactive proteomics. He spearheaded building the first proteome chip and developing multiplexed assay protocols for the protein microarray technology. Before joining Sandhill Crane Diagnostics, as the co-Founder and CSO, he worked for Cascade Biosytems Inc. as a Principle Scientist and Director of Commercialization. He has broad interests in molecular diagnostics, genomics, interactive proteomics, synthetic biology, and new technology management. He has a business degree in “Entrepreneurship and Life Sciences Management”, as well as MS in “Genetic Toxicology”.